WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1998051309) USE OF SEROTONIN AGONISTS TO ALLEVIATE DISORDERED BREATHING EPISODES IN A MAMMAL
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/1998/051309 International Application No.: PCT/US1998/009976
Publication Date: 19.11.1998 International Filing Date: 15.05.1998
Chapter 2 Demand Filed: 01.12.1998
IPC:
A61K 31/405 (2006.01) ,A61K 31/495 (2006.01)
Applicants: HENDRICKS, Joan, C.[US/US]; US (UsOnly)
KUBIN, Leszek[PL/US]; US (UsOnly)
PACK, Allan, I.[GB/US]; US (UsOnly)
VEASEY, Singrid, C.[US/US]; US (UsOnly)
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA[US/US]; Suite 300 3700 Market Street Philadelphia, PA 19104-3147, US (AllExceptUS)
Inventors: HENDRICKS, Joan, C.; US
KUBIN, Leszek; US
PACK, Allan, I.; US
VEASEY, Singrid, C.; US
Agent: LEARY, Kathryn, Doyle ; Panitch Schwarze Jacobs & Nadel, P.C. 22nd floor One Commerce Square 2005 Market Street Philadelphia, PA 19103-7086, US
Priority Data:
60/046,65416.05.1997US
Title (EN) USE OF SEROTONIN AGONISTS TO ALLEVIATE DISORDERED BREATHING EPISODES IN A MAMMAL
(FR) UTILISATION D'AGONISTES DE SEROTONINE POUR ATTENUER LES TROUBLES RESPIRATOIRES CHEZ UN MAMMIFERE
Abstract:
(EN) The invention includes compositions and methods for alleviating or preventing a disordered breathing episode. The composition of the invention comprises a serotonin re-uptake inhibitor and an agent selected from the group consisting of a serotonin precursor and a serotonin agonist. The method of the invention comprises administering the composition of the invention to a mammal, for example a human.
(FR) Cette invention se rapporte à des compositions et à des procédés visant à atténuer et à prévenir un trouble respiratoire épisodique. Les compositions de cette invention comportent un inhibiteur de recaptage de la sérotonine et un agent sélectionné dans le groupe constitué par un précurseur de la sérotonine et un agoniste de la sérotonine. Le procédé de cette invention consiste à administrer ladite composition à un mammifère, et notamment à un sujet humain.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, GW, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)